Evercore ISI Group downgraded SelectQuote from Outperform to In-Line and set a new price target of $11.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/21/2025 | $2.75 | Hold | Jefferies |
| 9/30/2024 | $4.50 | Buy | Craig Hallum |
| 2/29/2024 | $5.00 | Outperform | Noble Capital Markets |
| 4/1/2022 | $4.00 | Neutral | Credit Suisse |
| 2/8/2022 | $9.00 → $5.00 | Equal Weight | Barclays |
| 2/8/2022 | $13.00 → $3.00 | Sector Perform | RBC Capital |
| 2/8/2022 | $20.00 → $4.00 | Overweight → Neutral | Piper Sandler |
| 2/8/2022 | $14.00 → $4.00 | Outperform → Neutral | Credit Suisse |
144 - SelectQuote, Inc. (0001794783) (Subject)
10-Q - SelectQuote, Inc. (0001794783) (Filer)
8-K - SelectQuote, Inc. (0001794783) (Filer)
Jefferies initiated coverage of SelectQuote with a rating of Hold and set a new price target of $2.75
Craig Hallum initiated coverage of SelectQuote with a rating of Buy and set a new price target of $4.50
Noble Capital Markets initiated coverage of SelectQuote with a rating of Outperform and set a new price target of $5.00
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, announced today that Chief Financial Officer, Ryan Clement, and Head of Investor Relations, Matt Gunter, will participate in a fireside chat at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2026, beginning at approximately 11:00am ET. Management will also be available for 1x1 and small group investor meetings. About SelectQuote Founded in 1985, SelectQuote (NYSE:SLQT) pioneered the model of providing unbiased comparisons from multiple, highly rated insurance companies, allowing consumers to choose the policy and ter
Third Quarter of Fiscal Year 2026 – Consolidated Earnings Highlights Revenue of $430.9 million Net income of $40.2 million Adjusted EBITDA* of $44.6 million Fiscal Year 2026 Guidance Ranges: Revenue expected in a range of $1.61 billion to $1.71 billion Adjusted EBITDA* expected in a range of $90 million to $100 million Third Quarter Fiscal Year 2026 – Segment Highlights Senior Revenue of $182.9 million Adjusted EBITDA of $58.6 million Approved Medicare Advantage policies of 175,557 Healthcare Services Revenue of $199.4 million Adjusted EBITDA of $5.3 million 116,616 SelectRx members Life Revenue of $47.9 million Adjusted EBITDA of $6.1 mi
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing healthcare services platform, today announced it will release its fiscal third quarter 2026 financial results before market open on Tuesday, May 5, 2026. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (May 5, 2026) at 8:30 am ET to discuss the results. We encourage interested parties to access the live webcast of the event via our investor relations website https://ir.selectquote.com/investor-home/default.aspx or via this link. For those interested in dialing into the conference call, ple
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
Third Quarter of Fiscal Year 2026 – Consolidated Earnings Highlights Revenue of $430.9 million Net income of $40.2 million Adjusted EBITDA* of $44.6 million Fiscal Year 2026 Guidance Ranges: Revenue expected in a range of $1.61 billion to $1.71 billion Adjusted EBITDA* expected in a range of $90 million to $100 million Third Quarter Fiscal Year 2026 – Segment Highlights Senior Revenue of $182.9 million Adjusted EBITDA of $58.6 million Approved Medicare Advantage policies of 175,557 Healthcare Services Revenue of $199.4 million Adjusted EBITDA of $5.3 million 116,616 SelectRx members Life Revenue of $47.9 million Adjusted EBITDA of $6.1 mi
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing healthcare services platform, today announced it will release its fiscal third quarter 2026 financial results before market open on Tuesday, May 5, 2026. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (May 5, 2026) at 8:30 am ET to discuss the results. We encourage interested parties to access the live webcast of the event via our investor relations website https://ir.selectquote.com/investor-home/default.aspx or via this link. For those interested in dialing into the conference call, ple
Second Quarter of Fiscal Year 2026 – Consolidated Earnings Highlights Revenue of $537.1 million Net income of $69.3 million Adjusted EBITDA* of $84.7 million Fiscal Year 2026 Guidance Ranges: Revenue expected in a range of $1.61 billion to $1.71 billion Adjusted EBITDA* expected in a range of $90 million to $100 million Second Quarter Fiscal Year 2026 – Segment Highlights Senior Revenue of $261.5 million Adjusted EBITDA of $102.5 million Approved Medicare Advantage policies of 257,279 Healthcare Services Revenue of $230.7 million Adjusted EBITDA of $0.8 million 113,483 SelectRx members Life Revenue of $43.6 million Adjusted EBITDA of $5.6
Clement has served as Interim CFO since May 2022 SelectQuote, Inc. (NYSE:SLQT) today announced that the Board of Directors appointed Ryan Clement, SVP of Financial Planning & Analysis, to serve as the company's Chief Financial Officer. Clement was named interim CFO in May 2022. CEO Tim Danker commented, "Over the last year, Ryan has excelled as our Interim CFO and has demonstrated both the financial acumen and leadership qualities we are looking for in the company's next permanent CFO. Ryan has played a critical role in our strategic redesign that has vastly improved SelectQuote's operating results and financial stability and positions the company to execute on our objectives in the futur
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)